6 clinical trials found.
-
THE NEW YORK MOVEMENT DISORDER STUDY
Movement disorders represent a major public health crisis. Large longitudinal clinicopathological studies form the basis for studying the symptomatology, epidemiology, progression and pathogenesis of these ...Phase N/A
TRIAL ROLE: Principal Investigator
-
A Single Center Observational Study for the Characterization of Eye Movement Abnormalities Patients with Movement Disorders using the neuroClues Technology
Eye movements are frequently affected in individuals with different movement disorders, including Parkinson’s disease (PD), atypical Parkinsonism, but also cases of ataxia, myoclonus, and ...Phase N/A TRIAL ROLE: Principal Investigator
-
A SINGLE-CENTER OBSERVATIONAL STUDY OF THE IMPACT OF TREMOR AFFECTING THE VOICE ON DEGLUTITION
Tremor affects ~1% of the global population or nearly 80 million people. In spite of this staggering figure, both nomenclature and treatment approaches are inconsistent ...Phase N/A TRIAL ROLE: Co-Investigator
-
Movement Disorder Genomic Study
With the present study we aim to perform integrated genomic analysis and study on subject-specific cellular models in order to identify genetic causes of rare ...Phase N/A TRIAL ROLE: Sub Investigator
-
Genetic Screening Outcomes in Movement Disorders
Understanding the correlation between genetic mutations and causative pathogenic mechanisms and phenotypes in Movement Disorders may significantly contribute to implementing therapeutic approaches for these conditions ...Phase N/A TRIAL ROLE: Sub Investigator
-
Epigenetic Characterization of Immune Cells in Parkinson s disease and Prodromal Stages
Inflammation is one of the pathogenic mechanisms implicated in PD. To assess the activation and differences in regulation of the gene expression machinery in pre-motor ...Phase N/A TRIAL ROLE: Sub Investigator
